カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

在宅医療の世界市場予測（〜2025）：製品別（透析装置、人工呼吸器、ECG、杖、車椅子、活動モニター、ネブライザー、BPモニター）、サービス別（輸液療法、熟練看護、ホスピス）、疾患別、地域別

◆英語タイトル：Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Monitors, Nebulizers, BP Monitors), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication, Region - Global Forecast to 2025
◆商品コード：MD 1160
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2020年10月20日
◆ページ数：246
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥929,100見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
Marketsandmarkets社は在宅医療の世界市場が2020年1819億ドルから2025年2747億ドルまで、年平均8.6％成長すると予測しています。本調査レポートでは、在宅医療の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（治療、検査、スクリーニング・監視製品、在宅医療モビリティケア製品）分析、サービス別（スキルドナーシング、リハビリテーション療法、ホスピス・緩和ケア、非熟練ケア、呼吸療法）分析、疾患別（がん、呼吸器疾患、運動/運動障害、心血管障害・高血圧症、妊娠）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・在宅医療の世界市場規模：製品別（治療、検査、スクリーニング・監視製品、在宅医療モビリティケア製品）
・在宅医療の世界市場規模：サービス別（スキルドナーシング、リハビリテーション療法、ホスピス・緩和ケア、非熟練ケア、呼吸療法）
・在宅医療の世界市場規模：疾患別（がん、呼吸器疾患、運動/運動障害、心血管障害・高血圧症、妊娠）
・在宅医療の世界市場規模：地域別
・競争状況
・企業情報
【レポートの概要】

“The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period.” The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in-home care devices. On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.

“The cancer segment is expected to dominate the market during the forecast period.”
Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The cancer segment accounted for the largest share of the home healthcare market in 2019. The large share of this segment can primarily be attributed to the high prevalence of cancer cases across the globe and the transforming healthcare system, which allows the management of cancer at home.

“Testing, screening & monitoring segment will witness the highest growth in the home healthcare products market.”
Based on products, the home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products are expected to witness the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to factors such as the rising emphasis on preventive medicine and an increasing number of patients with chronic diseases. The potential to reduce healthcare complications and ensure the portability of devices with high accuracy is also expected to create a significant demand for monitoring and testing devices in the coming year.

“North America will dominate the market during the forecast period.”
Geographically, the home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the home healthcare market. The large share of this region in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and the presence of superior healthcare infrastructure.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation – C-level: 33%, D-level: 40%, and Others: 27%
• By Region – North America: 36%, Europe: 28%, Asia Pacific: 19%, and Rest of the World: 17%

List of Companies Profiled in the Report
• Fresenius SE & Co. KGaA (Germany)
• GE Healthcare (US)
• Linde plc (Ireland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• A&D Company (Japan)
• BAYADA Home Health Care (US)
• Invacare Corporation (US)
• Abbott (US), Amedisys (US)
• Kindred at Home (US)
• LHC Group, Inc. (US)
• OMRON Corporation (Japan)
• Koninklijke Philips N.V. (Netherlands)
• Drive DeVilbiss Healthcare (US)
• Hamilton Medical (Switzerland)
• Sunrise Medical (Germany)
• Roma Medical (UK)
• Caremax Rehabilitation Equipment Co., Ltd(China)
• Vitalograph (UK)
• advita Pflegedienst GmbH (Germany)
• RENAFAN GmbH (Germany)
• ADMR (France)
• Apex Medical Corporation (Taiwan)
• CONTEC MEDICAL SYSTEMS CO., LTD (China)
• Löwenstein Medical Technology GmbH + Co. KG. (Germany)

Research Coverage:
This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product, service, indication, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total home healthcare market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on home healthcare products and services offered by the top 25 players in the home healthcare market. The report analyses the home healthcare market by product, service, indication, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various home healthcare across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcare market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the home healthcare market.

【レポートの目次】

1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.3 MARKET SCOPE 33
FIGURE 1 HOME HEALTHCARE MARKET SEGMENTATION 33
1.3.1 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 34
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.2 SECONDARY DATA 36
2.2.1 SECONDARY SOURCES 36
2.3 PRIMARY DATA 37
2.3.1 KEY DATA FROM PRIMARY SOURCES 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 38
2.4 MARKET SIZE ESTIMATION 38
2.4.1 BOTTOM-UP APPROACH 38
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39
2.4.2 TOP-DOWN APPROACH 39
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 39
2.4.3 GROWTH FORECAST 39
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 6 DATA TRIANGULATION METHODOLOGY 40
2.6 ASSUMPTIONS FOR THE STUDY 41
3 EXECUTIVE SUMMARY 42
FIGURE 7 HOME HEALTHCARE MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 42
FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT, 2020 VS. 2025 (USD BILLION) 43
FIGURE 9 HOME HEALTHCARE MARKET, BY SERVICE, 2020–2025 (USD BILLION) 43
FIGURE 10 HOME HEALTHCARE MARKET, BY INDICATION, 2020 VS. 2025 (USD BILLION) 44
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL HOME HEALTHCARE MARKET 44
4 PREMIUM INSIGHTS 46
4.1 HOME HEALTHCARE MARKET OVERVIEW 46
FIGURE 12 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET
GROWTH DURING THE FORECAST PERIOD 46
4.2 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT
AND COUNTRY (2019) 47
FIGURE 13 WHEELCHAIRS DOMINATED THE MOBILITY CARE PRODUCTS MARKET
IN ASIA PACIFIC IN 2019 47
4.3 HOME HEALTHCARE MARKET, BY SERVICE, 2019 48
FIGURE 14 INFUSION THERAPY SERVICES TO WITNESS THE HIGHEST GROWTH
RATE DURING THE FORECAST PERIOD (2020-2025) 48
4.4 HOME HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT 48
FIGURE 15 JAPAN TO REGISTER THE FASTEST GROWTH DURING THE FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 16 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 49
5.2.1 MARKET DRIVERS 50
5.2.1.1 Rising aging population, high incidence of chronic diseases,
and need to expand healthcare access 50
TABLE 1 GLOBAL OVERVIEW OF THE RISE IN AGING POPULATION (MILLION) 50
5.2.1.2 Technological advancements 51
5.2.1.3 Increasing healthcare costs and the growing need for
affordable treatment options 51
5.2.2 RESTRAINTS 52
5.2.2.1 Changing reimbursement policies 52
5.2.2.2 Limited insurance coverage 52
5.2.2.3 Patient safety concerns 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Rising focus on telehealth 53
5.2.3.2 Untapped developing regions 53
5.2.4 CHALLENGES 54
5.2.4.1 Shortage of home care workers 54
5.2.5 COVID-19 IMPACT 55
5.3 PRICING ANALYSIS 56
5.4 VALUE CHAIN ANALYSIS 56
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND
ASSEMBLY PHASES 56
5.5 SUPPLY CHAIN ANALYSIS 57
FIGURE 18 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 57
5.6 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET 58
FIGURE 19 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET 58
 
6 HOME HEALTHCARE MARKET, BY PRODUCT 59
6.1 INTRODUCTION 60
TABLE 2 HOME HEALTHCARE MARKET, BY PRODUCT, 2018–2025 (USD BILLION) 60
TABLE 3 HOME HEALTHCARE PRODUCTS MARKET, BY REGION,
2018–2025 (USD BILLION) 60
6.2 THERAPEUTIC 61
TABLE 4 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 61
TABLE 5 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2025 (USD BILLION) 61
6.2.1 DIALYSIS EQUIPMENT 62
6.2.1.1 Dialysis equipment have gained significance due to their improved clinical outcomes and better quality of life for patients 62
TABLE 6 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 63
6.2.2 WOUND CARE PRODUCTS 63
6.2.2.1 Decreased cost and higher convenience and comfort of home
care will ensure the growth of this segment 63
TABLE 7 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 63
6.2.3 IV EQUIPMENT 64
6.2.3.1 IV equipment facilitate the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy 64
TABLE 8 IV EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 64
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 65
6.2.4.1 Rising number of obstructive sleep apnea (OSA) cases and the growing prevalence of sleep disorders to drive the market
for sleep apnea therapeutic devices 65
TABLE 9 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 65
6.2.5 INSULIN DELIVERY DEVICES 66
6.2.5.1 High incidence of diabetes to drive the insulin delivery
devices market 66
TABLE 10 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 66
6.2.6 OXYGEN DELIVERY SYSTEMS 66
6.2.6.1 Technological advancements of oxygen therapy products
to drive the market 66
TABLE 11 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 67
6.2.7 INHALERS 67
6.2.7.1 High incidence of asthma is the major factor driving
the inhalers market 67
TABLE 12 INHALERS MARKET, BY REGION, 2018–2025 (USD MILLION) 68
6.2.8 NEBULIZERS 68
6.2.8.1 Nebulizers are more effective as compared to oral dosages 68
TABLE 13 NEBULIZERS MARKET, BY REGION, 2018–2025 (USD MILLION) 69
6.2.9 VENTILATORS 69
6.2.9.1 Growing use of positive airway pressure devices for sleep apnea therapy is the key driver for the growth of the ventilators market in home care 69
TABLE 14 VENTILATORS MARKET, BY REGION, 2018–2025 (USD MILLION) 70
6.2.10 OTHER THERAPEUTIC PRODUCTS 70
TABLE 15 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 70
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 71
TABLE 16 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 71
TABLE 17 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION) 72
6.3.1 BLOOD GLUCOSE MONITORS 72
6.3.1.1 Increasing prevalence of diabetes to drive the market growth 72
TABLE 18 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 73
6.3.2 HEARING AIDS 73
6.3.2.1 High incidence of hearing impairment to drive the market 73
TABLE 19 HEARING AIDS MARKET, BY REGION, 2018–2025 (USD MILLION) 74
6.3.3 BLOOD PRESSURE MONITORS 74
6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth 74
TABLE 20 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 75
TABLE 21 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2018–2025 (MILLION UNITS) 75
6.3.4 ECG/EKG DEVICES 75
6.3.4.1 High prevalence of cardiovascular diseases to drive the market 75
TABLE 22 ECG/EKG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 76
6.3.5 OVULATION AND PREGNANCY TEST KITS 76
6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits 76
TABLE 23 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 77
6.3.6 PULSE OXIMETERS 77
6.3.6.1 Pulse oximeters are used to measure the oxygen saturation
in the blood 77
TABLE 24 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 78
TABLE 25 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS) 78
6.3.7 HEART RATE MONITORS 78
6.3.7.1 Ability to continuously monitor the critical cardiac parameters
to drive the demand for heart rate monitors 78
TABLE 26 HEART RATE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION) 79
6.3.8 COAGULATION MONITORING PRODUCTS 79
6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for the
safe and effective management 79
TABLE 27 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 80
6.3.9 FETAL MONITORING DEVICES 80
6.3.9.1 High risk of preterm birth to drive the market for fetal
monitoring devices 80
TABLE 28 FETAL MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 81
6.3.10 HIV TEST KITS 81
6.3.10.1 Rising prevalence of HIV to drive the market 81
TABLE 29 HIV TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 81
6.3.11 HOLTER AND EVENT MONITORS 82
6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market 82
TABLE 30 HOLTER AND EVENT MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 82
6.3.12 TEMPERATURE MONITORING DEVICES 83
6.3.12.1 Technological innovations and increasing awareness on the use
of temperature monitoring devices for personal care to drive
the growth of this market 83
TABLE 31 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 83
6.3.13 CHOLESTEROL TESTING PRODUCTS 83
6.3.13.1 Rising obesity levels and cardiovascular disorder incidence
are the key factors supporting the market growth 83
TABLE 32 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 84
6.3.14 DRUG AND ALCOHOL TEST KITS 84
6.3.14.1 Consumption of drugs among teens supports the market growth 84
TABLE 33 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 85
6.3.15 PEAK FLOW METERS 85
6.3.15.1 Peak flow meters are used to monitor the person’s ability to breathe 85
TABLE 34 PEAK FLOW METERS MARKET, BY REGION, 2018–2025 (USD MILLION) 85
6.3.16 COLON CANCER TEST KITS 86
6.3.16.1 High incidence of colorectal cancer to support the market growth 86
TABLE 35 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 86
6.3.17 ACTIVITY MONITORS & WRIST BANDS 86
6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors 86
TABLE 36 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2018–2025 (USD MILLION) 87
6.3.18 EEG DEVICES 87
6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices 87
TABLE 37 EEG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 88
6.3.19 HOME SLEEP TESTING DEVICES 88
6.3.19.1 Cost-effectiveness of home-based sleep tests expected to fuel the growth of home sleep testing devices 88
TABLE 38 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 89
6.3.20 HOME HEMOGLOBIN A1C TEST KITS 89
6.3.20.1 High incidence of diabetes to drive the market 89
TABLE 39 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 89
6.4 HOME HEALTHCARE MOBILITY CARE PRODUCTS 90
TABLE 40 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 90
TABLE 41 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY REGION, 2018–2025 (USD MILLION) 90
6.4.1 WHEELCHAIRS 91
6.4.1.1 Increased preference for wheelchairs to support the market growth 91
TABLE 42 WHEELCHAIRS MARKET, BY REGION, 2018–2025 (USD MILLION) 91
6.4.2 MOBILITY SCOOTERS 91
6.4.2.1 Mobility scooters help users to travel long distances 91
TABLE 43 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2025 (USD MILLION) 92
6.4.3 WALKERS AND ROLLATORS 92
6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking 92
TABLE 44 WALKERS AND ROLLATORS MARKET, BY REGION,
2018–2025 (USD MILLION) 92
6.4.4 CRUTCHES 93
6.4.4.1 Axilla crutches are the most preferred as they are easy to use
and are often used by people who have a temporary injury 93
TABLE 45 CRUTCHES MARKET, BY REGION, 2018–2025 (USD MILLION) 93
6.4.5 CANES 94
6.4.5.1 Canes are the most common assistive devices 94
TABLE 46 CANES MARKET, BY REGION, 2018–2025 (USD MILLION) 94
7 HOME HEALTHCARE MARKET, BY SERVICE 95
7.1 INTRODUCTION 96
TABLE 47 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019 96
TABLE 48 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD BILLION) 97
TABLE 49 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 97
7.2 SKILLED NURSING 97
7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD 97
TABLE 50 SKILLED NURSING SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 98
 
7.3 REHABILITATION THERAPY 98
7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY 98
TABLE 51 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 99
7.4 HOSPICE AND PALLIATIVE CARE 99
7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE AND PALLIATIVE
CARE SERVICES 99
TABLE 52 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 100
7.5 UNSKILLED CARE 100
7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER
COMFORT AND SECURITY TO PATIENTS 100
TABLE 53 UNSKILLED CARE SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 101
7.6 RESPIRATORY THERAPY 101
7.6.1 THE GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE THE MARKET 101
TABLE 54 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2018–2025 (USD BILLION) 102
7.7 INFUSION THERAPY 102
7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES 102
TABLE 55 INFUSION THERAPY SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 103
7.8 PREGNANCY CARE 103
7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE
HIGH-RISK PREGNANCIES AND COMPLICATIONS 103
TABLE 56 PREGNANCY CARE SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 103
8 HOME HEALTHCARE MARKET, BY INDICATION 104
8.1 INTRODUCTION 105
TABLE 57 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION) 105
8.2 CANCER 105
8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE THE MARKET GROWTH 105
TABLE 58 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2018–2025 (USD BILLION) 106
8.3 RESPIRATORY DISEASES 106
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO HAVE A POSITIVE IMPACT ON THIS SEGMENT 106
TABLE 59 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD BILLION) 106
8.4 MOVEMENT/MOBILITY DISORDERS 107
8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS 107
TABLE 60 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018–2025 (USD BILLION) 107
8.5 CARDIOVASCULAR DISORDERS & HYPERTENSION 107
8.5.1 RISING INCIDENCE OF HYPERTENSION AND CARDIOVASCULAR DISORDERS TO DRIVE THE GROWTH OF THIS SEGMENT 107
TABLE 61 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISORDERS & HYPERTENSION, BY REGION, 2018–2025 (USD BILLION) 108
8.6 PREGNANCY 108
8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY
TO DRIVE THE GROWTH OF THIS SEGMENT 108
TABLE 62 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2018–2025 (USD BILLION) 108
8.7 WOUND CARE 109
8.7.1 RISING PREVALENCE OF ROAD ACCIDENTS AND TRAUMA INJURIES
DRIVE THE MARKET GROWTH 109
TABLE 63 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2018–2025 (USD BILLION) 109
8.8 DIABETES 109
8.8.1 INCREASING INCIDENCE OF DIABETES TO DRIVE THE GROWTH OF THIS MARKET 109
TABLE 64 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2018–2025 (USD BILLION) 110
8.9 HEARING DISORDERS 110
8.9.1 AGING IS ONE OF THE RISK FACTORS FOR HEARING DISORDERS 110
TABLE 65 GLOBAL INCIDENCE OF HEARING DISORDERS 111
TABLE 66 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,
2018–2025 (USD BILLION) 111
8.10 OTHER INDICATIONS 112
TABLE 67 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2018–2025 (USD BILLION) 112
9 HOME HEALTHCARE MARKET, BY REGION 113
9.1 INTRODUCTION 114
TABLE 68 HOME HEALTHCARE MARKET, BY REGION, 2018–2025 (USD BILLION) 114
9.2 NORTH AMERICA 114
TABLE 69 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2018–2025 (USD BILLION) 114
FIGURE 20 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 115
TABLE 70 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE,
2018–2025 (USD BILLION) 115
TABLE 71 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 72 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 73 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 74 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 75 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD BILLION) 118
TABLE 76 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD BILLION) 118
9.2.1 US 119
9.2.1.1 US to dominate the North American home healthcare market 119
TABLE 77 US: KEY INDICATORS 120
TABLE 78 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD BILLION) 120
TABLE 79 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 80 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 81 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 82 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 83 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 84 US: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD BILLION) 123
9.2.2 CANADA 124
9.2.2.1 Rising aging population drives the market in the country 124
TABLE 85 CANADA: KEY INDICATORS 125
TABLE 86 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 87 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 88 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 89 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 90 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 91 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 92 CANADA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 128
9.3 EUROPE 129
TABLE 93 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION,
2018–2025 (USD BILLION) 129
TABLE 94 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 95 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 96 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 97 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 98 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 99 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 100 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 132
9.3.1 GERMANY 133
9.3.1.1 Germany to dominate the European Home Healthcare Market 133
TABLE 101 GERMANY: KEY INDICATORS 134
TABLE 102 GERMANY: HOME HEALTHCARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 103 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 104 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 105 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 106 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 107 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 108 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 137
9.3.2 FRANCE 138
9.3.2.1 Government support and initiatives taken by market players
to drive the home healthcare market 138
TABLE 109 FRANCE: KEY INDICATORS 138
TABLE 110 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 111 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 112 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 113 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 114 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 115 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 116 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 141
9.3.3 UK 142
9.3.3.1 High burden of chronic diseases to drive the market in the country 142
TABLE 117 UK: KEY INDICATORS 142
TABLE 118 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 119 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 143
TABLE 120 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 121 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 144
TABLE 122 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 123 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 124 UK: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 145
9.3.4 ITALY 146
9.3.4.1 Rising geriatric population and the favorable government
policy to drive the market in the country 146
TABLE 125 ITALY: KEY INDICATORS 146
TABLE 126 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 146
TABLE 127 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 128 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 147
TABLE 129 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 130 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 131 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 132 ITALY: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 149
9.3.5 SPAIN 150
9.3.5.1 Increasing chronic conditions coupled with higher life expectancy
to drive the market in the country 150
TABLE 133 SPAIN: KEY INDICATORS 150
TABLE 134 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 150
TABLE 135 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 136 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 137 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 138 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 139 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 140 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 153
9.3.6 REST OF EUROPE 154
9.3.6.1 Growth in the target patient population to drive the market
in the region 154
TABLE 141 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2016 (% OF GDP) 154
TABLE 142 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 154
TABLE 143 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 144 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 155
TABLE 145 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 156
TABLE 146 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 156
TABLE 147 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 148 ROE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 157
9.4 ASIA PACIFIC 158
TABLE 149 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY,
2018–2025 (USD BILLION) 158
FIGURE 21 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT 159
TABLE 150 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 159
TABLE 151 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 160
TABLE 152 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 160
TABLE 153 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 161
TABLE 154 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 161
TABLE 155 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 162
TABLE 156 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 162
9.4.1 JAPAN 163
9.4.1.1 Growing geriatric population in the country to drive the
home healthcare market 163
TABLE 157 JAPAN: KEY INDICATORS 163
TABLE 158 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 163
TABLE 159 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 164
TABLE 160 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 164
TABLE 161 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 165
TABLE 162 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 165
TABLE 163 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 166
TABLE 164 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 166
9.4.2 CHINA 167
9.4.2.1 Healthcare development and reforms will drive the market
in the country 167
TABLE 165 CHINA: KEY INDICATORS 167
TABLE 166 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2015–2022 (USD MILLION) 167
TABLE 167 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 168
TABLE 168 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 168
TABLE 169 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 169
TABLE 170 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 169
TABLE 171 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 170
TABLE 172 CHINA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 170
9.4.3 INDIA 171
9.4.3.1 Increasing target patient population to drive the market
in the country 171
TABLE 173 INDIA: KEY INDICATORS 172
TABLE 174 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 175 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 172
TABLE 176 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 177 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 178 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 179 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 175
TABLE 180 INDIA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 175
9.4.4 REST OF ASIA PACIFIC 176
TABLE 181 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 176
TABLE 182 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 176
TABLE 183 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 177
TABLE 184 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 178
TABLE 185 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 178
TABLE 186 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 179
TABLE 187 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 179
9.5 REST OF THE WORLD 180
TABLE 188 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 180
TABLE 189 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 180
TABLE 190 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 181
TABLE 191 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 182
TABLE 192 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 182
TABLE 193 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 183
TABLE 194 ROW: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2025 (USD MILLION) 183
10 COMPETITIVE LANDSCAPE 184
10.1 OVERVIEW 184
FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020 184
FIGURE 23 MARKET EVOLUTION FRAMEWORK 185
10.2 MARKET SHARE ANALYSIS, 2019 186
FIGURE 24 HOME BLOOD PRESSURE MONITORS MARKET SHARE, BY KEY PLAYER, 2019 186
FIGURE 25 GLOBAL HEARING AID MARKET SHARE, BY KEY PLAYER, 2019 187
FIGURE 26 HOME DIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2019 188
10.3 COMPETITIVE SCENARIO 189
10.3.1 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES (2017–2020) 189
10.3.2 PRODUCT LAUNCHES & APPROVALS (2017-2020) 189
10.3.3 EXPANSIONS (2017-2020) 190
10.3.4 ACQUISITIONS (2017-2020) 190
10.4 COMPANY EVALUATION QUADRANT (2020) 191
10.4.1 VENDOR INCLUSION CRITERIA 191
10.4.2 STAR 191
10.4.3 EMERGING LEADERS 191
10.4.4 PERVASIVE 191
10.4.5 PARTICIPANT 192
FIGURE 27 MNM VENDOR DIVE COMPARISON MATRIX: HOME HEALTHCARE MARKET 192
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) FOR THE HOME HEALTHCARE SERVICES MARKET 192
10.5.1 PROGRESSIVE COMPANIES 192
10.5.2 STARTING BLOCKS 193
10.5.3 RESPONSIVE COMPANIES 193
10.5.4 DYNAMIC COMPANIES 193
FIGURE 28 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: HOME HEALTHCARE MARKET 193
 
11 COMPANY PROFILES 194
(Business Overview, products & services offered, Recent Developments, MnM View)*
11.1 FRESENIUS 194
FIGURE 29 FRESENIUS: COMPANY SNAPSHOT (2019) 194
TABLE 195 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EURO TO USD) 195
11.2 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 198
FIGURE 30 GENERAL ELECTRIC COMPANY SNAPSHOT: COMPANY SNAPSHOT (2019) 198
11.3 LINDE PLC 200
FIGURE 31 LINDE PLC: COMPANY SNAPSHOT (2019) 200
11.4 ROCHE 203
FIGURE 32 ROCHE: COMPANY SNAPSHOT (2019) 203
TABLE 196 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF CHF TO USD) 203
11.5 A&D COMPANY 206
FIGURE 33 A&D COMPANY: COMPANY SNAPSHOT (2019) 206
TABLE 197 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF JPY TO USD) 206
11.6 BAYADA HOME HEALTH CARE 208
11.7 INVACARE CORPORATION 211
FIGURE 34 INVACARE CORPORATION: COMPANY SNAPSHOT (2019) 211
11.8 ABBOTT LABORATORIES 213
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 213
11.9 AMEDISYS 217
FIGURE 36 AMEDISYS: COMPANY SNAPSHOT (2019) 217
11.10 KINDRED AT HOME 221
11.11 LHC GROUP 223
FIGURE 37 LHC GROUP: COMPANY SNAPSHOT (2019) 223
11.12 OMRON CORPORATION 228
FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2019) 228
11.13 KONINKLIJKE PHILIPS N.V. 231
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 231
11.14 DRIVE DEVILBISS HEALTHCARE 236
11.15 HAMILTON MEDICAL AG 238
*Details on Business Overview, products & services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11.16 SUNRISE MEDICAL 239
11.17 ROMA MEDICAL 239
11.18 CAREMAX REHABILITATION EQUIPMENT CO., LTD. 240
11.19 VITALOGRAPH 240
11.20 ADVITA PFLEGEDIENST GMBH 241
11.21 RENAFAN GMBH 241
11.22 ADMR 242
11.23 APEX MEDICAL CORP. 243
11.24 CONTEC MEDICAL SYSTEMS CO., LTD 243
11.25 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG. 244
12 APPENDIX 245
12.1 DISCUSSION GUIDE 245
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249
12.3 AVAILABLE CUSTOMIZATIONS 251
12.4 RELATED REPORTS 251
12.5 AUTHOR DETAILS 253



【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[在宅医療の世界市場予測（〜2025）：製品別（透析装置、人工呼吸器、ECG、杖、車椅子、活動モニター、ネブライザー、BPモニター）、サービス別（輸液療法、熟練看護、ホスピス）、疾患別、地域別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 長期ケアの世界市場：サービス別（在宅医療、ホスピス、介護、生活支援施設）、地域別（北米、ヨーロッパ、APAC、ラテンアメリカ、MEA）
    GV20MY055 / Grand View Research / 2020年3月23日 / 本調査レポートでは、長期ケアの世界市場について調査・分析し、調査目的、エグゼクティブサマリー、市場要因・動向・範囲、サービス別（在宅医療、ホスピス、介護、生活支援施設）分析、地域別（北米、ヨーロッパ、APAC、ラテンアメリカ、MEA）分析、調査手法・範囲などの構成でお届けいたします。 ・調査目的 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・長期ケアの世界市場：サービス別（在宅医療、ホスピス、介護、生活支援施設） ・長期ケアの世界市場：地域別（北米、ヨーロッパ、APAC、ラテンアメリカ、MEA） ・調査手法・範囲...The global long term care market size is expected to reach USD 1.7 trillion by 2027, expanding at a CAGR of 7.1%, according to a new report by Grand View Research, Inc. The market is expected to grow primarily owing to the rising prevalence of target diseases, especially Alzheimer’s and other dementias, among the aging population. In addition to this, increasing awareness about different long term care (LTC) facilities and the increasing medical coverage for home healthcare are likely to benefit LTC market growth. According to World Population Prospects 2019, the global population aged 65 years and above was 703...
  2. 呼吸ケア機器の世界市場：製品別（治療用（人工呼吸器、マスク、パップデバイス、吸入器、ネブライザー）、モニタリング（パルスオキシメーター、カプノグラフ）、診断、消耗品）、エンドユーザー別（病院、在宅医療）、適応症別（COPD、喘息、慢性感染症） 、地域別
    BWC20MY001 / BlueWeave Consulting / 2019年10月 / 本調査レポートでは、呼吸ケア機器の世界市場について調査・分析し、調査フレームワーク、調査手法、エグゼクティブサマリー、産業インサイト、市場概要、北米市場、ヨーロッパ市場、アジア太平洋市場、中南米市場、中東・アフリカ市場、企業情報、戦略提言などのデータを収録しています。 ・調査フレームワーク ・調査手法 ・エグゼクティブサマリー ・世界の呼吸ケア機器産業インサイト ・世界の呼吸ケア機器市場概要 ・北米の呼吸ケア機器市場 ・ヨーロッパの呼吸ケア機器市場 ・アジア太平洋の呼吸ケア機器市場 ・中南米の呼吸ケア機器市場...BlueWeave Consulting review study of the Respiratory Care Devices Market anticipated to propel with a significant CAGR of over 8% in the forecasted period of 2019-2025. Rising urbanization, changing lifestyle, and food habits coupled with an increasing number of geriatric population is the key factor anticipated to propel the growth of the global respiratory care device market. The rising prevalence rate of the geriatric population expected to rise the demand of homecare –setting facility in the market and the changing food habits such as the preference of junk food over healthy food leads to a number of chronic and other...
  3. 世界の耐久性医療機器（DME）市場規模・予測2017-2025：商品別（パーソナルモビリティデバイス、車いす、スクーター、歩行器、杖、ドアオープナー、その他、トイレ安全装置・医療機器、コモド・トイレ、マットレス・ベッド用装置、監視・治療用デバイス、血糖値モニター、CPM、輸液パンプ、ネブライザー、酸素装置、CPAP、サクションパンプ、牽引装置、その他）、エンドユーズ別（病院、緊急外来、長期滞在センター、ホームケア、その他）地域別
    BZW803211 / Bizwit Research & Consulting / 2018年3月4日 / Bizwit Researchが発行した当調査レポートでは、世界の耐久性医療機器（DME）市場について調査・分析し、世界の耐久性医療機器（DME）市場規模、種類別分析、セグメント別分析、地域別分析（アメリカ市場、アジア市場、ヨーロッパ市場など）、市場動向、世界の耐久性医療機器（DME）関連企業分析などを含め、以下の構成でお届けいたします。...Global Durable Medical Equipment (DME) Market industry valued approximately USD 140 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2017-2025. Durable Medical Equipment (DME) are indented for safety, monitoring, and diagnosis of disease and are used in variety of applications. Some of the major growth driving factors are increasing demand for powered wheelchair and technological advancement. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed...
  4. マウスモデルの世界市場予測（〜2025）：種類別（近交系、ノックアウト）、技術別（CRISPR、TALEN、ZFN）、用途別（腫瘍学、糖尿病、免疫学）、サービス別（育種、凍結保存、遺伝子検査）、ケア製品別（ケージ、寝具、飼料）、地域別
    BT 2192 / MarketsandMarkets / 2020年9月16日 / Marketsandmarkets社はマウスモデルの世界市場が2020年14億ドルから2025年19億ドルまで、年平均6.4％成長すると予測しています。本調査レポートでは、マウスモデルの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、規制評価、臨床試験評価、マウス種類別（近親交配マウス、アウトブレッドマウス、遺伝子改変マウス、ハイブリッド/先天性マウス、条件付き/外科的改変マウス）分析、サービス別（育種、凍結保存、検疫、派生、モデルライセンス供与）分析、技術別（CRISPR/CAS9、マイクロインジェクション、胚性幹細胞注射、核移植、その他）分析、用途別（腫瘍学研究、免疫学・炎症研究、内分泌代謝研究、心血管研究、中枢神経系（CNS）研究）分析、マウスケア製品別（ケージ、飼料、寝具）分析、地域別分析、競争状況、企業評価・情報などをまとめております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・規制評価 ・臨床試験評価 ・マウスモデルの世界市場規模：マウス種類別（近親交配マウス、アウトブレッドマウス、遺伝子改変マウス、ハイブリッド/先天性マウス、条件付き/外科的改変マウス） ・マウスモデルの世界市場規模：サービス別（育種、凍結保存、検疫、派生、モデルライセンス供与）...“Increasing implication of mouse clinical trials (MCTs) and ongoing innovation in mice models are set to drive the mice model market.” The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. The major factors driving the growth of this market are the Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes and ongoing innovations in mice models are driving the growth of the global mice model industry. However, Implementation...
  5. 微生物同定の世界市場予測（〜2025）：製品・サービス別（機器・ソフトウェア、消耗品、サービス）、方法別（フェノティピック、プロテオミクス）、技術別（質量分析、PCR）、用途別（診断、食品検査）、エンドユーザー別（病院）
    BT 2606 / MarketsandMarkets / 2020年10月20日 / Marketsandmarkets社は微生物同定の世界市場が2020年32億ドルから2025年57億ドルまで、年平均12.2％成長すると予測しています。本調査レポートでは、微生物同定の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別（機器・ソフトウェア、消耗品、サービス）分析、方法別（フェノティピック、プロテオミクス、遺伝子型）分析、技術別（質量分析、PCR、フローサイトメトリー、顕微鏡検査、その他）分析、用途別（診断、医薬品、食品検査、飲料検査、環境）分析、エンドユーザー別（病院、診断研究所、血液銀行、製薬会社・委託研究機関、食品製造会社、飲料製造会社、その他）分析、地域別分析、競争状況、企業評価・情報などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・微生物同定の世界市場規模：製品・サービス別（機器・ソフトウェア、消耗品、サービス） ・微生物同定の世界市場規模：方法別（フェノティピック、プロテオミクス、遺伝子型） ・微生物同定の世界市場規模：技術別（質量分析、PCR、フローサイトメトリー、顕微鏡検査、その他） ・微生物同定の世界市場規模：用途別（診断、医薬品、食品検査、飲料検査、環境）...“The global microbial identification market size is estimated to be USD 3.2 billion in 2020 and projected to reach USD 5.7 billion by 2025, at a CAGR of 12.2%.” Growth in this market is largely driven by the rising incidence of infectious diseases and the increasing frequency of pandemics, technological advancements, increasing food safety concerns, and increasing government initiatives and funding to detect and control antimicrobial-resistant species “By consumables type segment, the panels/ID cards & media segment accounted for the fastest growing consumable segment of the microbial identification market” On the basis of product & service type, the consumables segment...
  6. 呼吸ケア機器の世界市場予測：製品別（治療用（人工呼吸器、マスク、PAPデバイス、吸入器、ネブライザー））、モニタリング（パルスオキシメーター、カプノグラフ）、診断、消耗品）、エンドユーザー別（病院、在宅医療）、疾患別
    MD 1583 / MarketsandMarkets / 2020年6月29日 / MarketsandMarkets社は呼吸ケア機器の世界市場が2020年299億ドルから2025年160億ドルまで、年平均-12.5%％成長すると見込んでいます。本調査レポートでは、呼吸ケア機器の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場動向、製品別（治療装置、監視装置、診断装置、消耗品・付属品） 分析、疾患別（慢性閉塞性肺疾患、睡眠時無呼吸、喘息、感染症、その他）分析、エンドユーザー別（病院、ホームケア設定、外来診療センター）分析、地域別分析、競争状況、企業概要などを含めています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・市場動向 ・呼吸ケア機器の世界市場規模：製品別（治療装置、監視装置、診断装置、消耗品・付属品） ・呼吸ケア機器の世界市場規模：疾患別（慢性閉塞性肺疾患、睡眠時無呼吸、喘息、感染症、その他）...“Outbreak of infectious diseases affecting the respiratory system is expected to drive market growth.” The respiratory care devices market is expected to reach USD 29.9 billion by 2025 from USD 16.0 billion in 2019, at a CAGR of -12.5% during the forecast period of 2020 to 2025. Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for respiratory care devices. Thus, the respiratory care devices market witnessed a CAGR of 261.1% between 2019 and 2020. In 2020, the respiratory care devices market reached USD 58.1 billion. The growth of this market is mainly attributed...
  7. ラベルフリー検出の世界市場予測（〜2025）：製品・サービス別（機器、消耗品（バイオセンサーチップ）、ソフトウェア）、技術別（表面プラズモン共鳴）、用途別（結合キネティクス）、エンドユーザー別（製薬会社、バイオテクノロジー企業）
    BT 2455 / MarketsandMarkets / 2020年9月10日 / Marketsandmarkets社はラベルフリー検出の世界市場が2020年431百万ドルから2025年626百万ドルまで、年平均7.7％成長すると予測しています。本調査レポートでは、ラベルフリー検出の世界市場を調査・分析することにより、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品・サービス別（機器、消耗品、ソフトウェア・サービス）分析、技術別（表面プラズモン共鳴、示差走査熱量測定、バイオレイヤーインターフェロメトリー、等温滴定熱量測定、その他）分析、用途別（結合キネティクス、結合熱力学、ヒット確認、リードジェネレーション、内因性受容体検出）分析、エンドユーザー別（製薬・バイオテクノロジー企業、学術・研究機関、契約研究組織、その他）分析、地域別分析、競争状況、企業評価マトリックス及び企業情報など、今後の方向性を明らかに致します。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・ラベルフリー検出の世界市場規模：製品・サービス別（機器、消耗品、ソフトウェア・サービス） ・ラベルフリー検出の世界市場規模：技術別（表面プラズモン共鳴、示差走査熱量測定、バイオレイヤーインターフェロメトリー、等温滴定熱量測定、その他） ・ラベルフリー検出の世界市場規模：用途別（結合キネティクス、結合熱力学、ヒット確認、リードジェネレーション、内因性受容体検出） ・ラベルフリー検出の世界市場規模：エンドユーザー別（製薬・バイオテクノロジー企業、学術・研究機関、契約研究組織、その他）...“Introduction of technologically advanced products, and a growing number of drug discovery programs through academic-industrial partnerships are set to drive the label-free detection market.’’ The global label-free detection market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%. Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies. “By consumables type segment, the biosensor chips accounted for the fastest growing consumable segment of the...
  8. 世界のラットモデル市場規模・予測2017-2025：種類別（ハイブリッド、非近交系ラット、近交系ラット、ノックアウトラット、条件付け、免疫不全）、技術別（微量注入、核移植）、サービス別（繁殖、細胞凍結、検疫）、用途別（腫瘍学、オンコロジー、免疫学）、エンドユーズ別（CROs、学術研究機関、ヘルスケア企業）地域別
    BZW803223 / Bizwit Research & Consulting / 2018年3月4日 / Bizwit Researchが発行した当調査レポートでは、世界のラットモデル市場について調査・分析し、世界のラットモデル市場規模、種類別分析、セグメント別分析、地域別分析（アメリカ市場、アジア市場、ヨーロッパ市場など）、市場動向、世界のラットモデル関連企業分析などを含め、以下の構成でお届けいたします。...Global Rat Model Market industry valued approximately USD 415.3 million in 2016 is anticipated to grow with a healthy growth rate of more than 8.30% over the forecast period 2017-2025. A Rat Model has been used frequently in drug development, toxicology, and various biomedical fields. Ongoing research on neurology disorder and cancer fuel up the demand of rat models in coming year. A variety of rat models are available for purpose of research and advancement i.e. genetically modified or conditioned rats. Outbred rat segment has a majority of the market since 2016. The extensive use of outbred rats in toxicology...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆